Last update 13 Aug 2026
Shanghai Huilun Life Science & Technology Co. Ltd.

Shanghai Huilun Life Science & Technology Co. Ltd.

Private Company|2004|Shanghai Shi, China|
www.huilunbio.com

Overview

Tags

Neoplasms
Other Diseases
Nervous System Diseases
Small molecule drug
Chemical drugs

Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Disease DomainCount
Neoplasms12
Nervous System Diseases9
Infectious Diseases9
Immune System Diseases8
Endocrinology and Metabolic Disease4
Top 5 Drug TypeCount
Small molecule drug23
Chemical drugs7
Unknown1
Top 5 TargetCount
IRAK4(Interleukin-1 receptor-associated kinase 4)3
ELA2(Leukocyte elastase)3
5-HT2A receptor(Serotonin 2a (5-HT2a) receptor)2
Nav1.8(Sodium channel protein type X alpha subunit)2
DPP-1(Cathepsin C)2

Related

31
Drugs associated with Shanghai Huilun Life Science & Technology Co. Ltd.
Relugolix
Target
GnRHR
Mechanism
GnRHR antagonists
Active Org.
Sumitomo Pharma Switzerland GmbH [+11]
Originator Org.
Takeda Pharmaceutical Co., Ltd.Takeda Pharmaceutical Co., Ltd.
Active Indication
Advanced Prostate Carcinoma [+9]
Inactive Indication
Dysmenorrhea [+4]
Drug Highest PhaseApproved
First Approval Ctry. / Loc.
Japan
First Approval Date08 Jan 2019
Levoleucovorin
Target-
Mechanism-
Active Org.
Pfizer Inc.Pfizer Inc. [+3]
Originator Org.
Shanghai Huilun Life Science & Technology Co. Ltd.Shanghai Huilun Life Science & Technology Co. Ltd. [+1]
Active Indication
Stomach Cancer [+6]
Inactive Indication
Pancreatic Cancer
Drug Highest PhaseApproved
First Approval Ctry. / Loc.
Switzerland
First Approval Date16 Oct 2009
Sivelestat Sodium Hydrate
Target
ELA2
Mechanism
ELA2 inhibitors
Active Org.
Shanghai Huilun Pharmaceutical Co., Ltd.Shanghai Huilun Pharmaceutical Co., Ltd. [+5]
Originator Org.
Ono Pharmaceutical Co., Ltd.Ono Pharmaceutical Co., Ltd.
Active Indication
Respiratory Distress Syndrome, Acute [+4]
Inactive Indication
Respiratory Distress Syndrome, Adult [+1]
Drug Highest PhaseApproved
First Approval Ctry. / Loc.
Japan
First Approval Date11 Apr 2002
72
Clinical Trials associated with Shanghai Huilun Life Science & Technology Co. Ltd.
NCT07758920
/ RecruitingPhase 2
A Clinical Trial to Evaluate the Efficacy and Safety of HL-1186 Tablet in the Treatment of Postherpetic Neuralgia
NCT07709598
/ RecruitingPhase 2/3
A Multicenter, Randomized, Double-Blind, Placebo- and Active-Controlled Parallel-Group Phase II/III Clinical Trial to Evaluate the Efficacy and Safety of HL-1186 Tablets for Postoperative Analgesia in Abdominal Surgery
NCT07699601
/ RecruitingPhase 2/3
A Multicenter, Randomized, Double-Blind, Placebo- and Active-Controlled Parallel-Group Phase II/III Clinical Trial to Evaluate the Efficacy and Safety of HL-1186 Tablets for Postoperative Analgesia in Orthopedic Surgery
100 Clinical Results associated with Shanghai Huilun Life Science & Technology Co. Ltd.
Login to view more data
0 Patents (Medical) associated with Shanghai Huilun Life Science & Technology Co. Ltd.
Login to view more data
100 Deals associated with Shanghai Huilun Life Science & Technology Co. Ltd.
Login to view more data
100 Translational Medicine associated with Shanghai Huilun Life Science & Technology Co. Ltd.
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 16 Aug 2026

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Discovery
14
3
Preclinical
Phase 1
4
3
Phase 2
Phase 3
5
2
Approved
Login to view more data

Current Projects

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
Hiro LS Researcher
The AI Search Engine Built to Accelerate Biopharma Decisions
Search across billion-scale life sciences data to uncover signals, validate evidence, and act with confidence.
Ask any biopharma research question→
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, Patsnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Discover Synapse Data Servers
Synapse data is now integrated into the PatSnap LS Model Context Protocol (MCP) service. Customize your LLM agent now using our MCP server!
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free